BNP Paribas Financial Markets’s Ascendis Pharma A/S ASND Stock Holding History

BNP Paribas Financial Markets’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.3M	Sell	173,449 -135,724	-44%	-$31.7M	0.02%	804
2026 Q1	$70.7M	Buy	309,173 +2,087	+0.7%	+$468K	0.03%	532
2025 Q4	$65.5M	Buy	307,086 +68,555	+29%	+$14.2M	0.03%	561
2025 Q3	$47.4M	Buy	238,531 +72,864	+44%	+$13.6M	0.03%	653
2025 Q2	$28.6M	Buy	165,667 +23,043	+16%	+$3.75M	0.02%	854
2025 Q1	$22.2M	Buy	142,624 +42,601	+43%	+$6.09M	0.01%	989
2024 Q4	$13.8M	Sell	100,023 -78,682	-44%	-$10.3M	0.01%	1188
2024 Q3	$26.7M	Buy	178,705 +50,631	+40%	+$6.84M	0.02%	741
2024 Q2	$17.5M	Buy	128,074 +52,534	+70%	+$7.15M	0.01%	835
2024 Q1	$11.4M	Buy	75,540 +73,796	+4,231%	+$10.5M	0.01%	1032
2023 Q4	$220K	Buy	1,744 +999	+134%	+$99.6K	﹤0.01%	3168
2023 Q3	$69.8K	Sell	745 -203	-21%	-$19K	﹤0.01%	3405
2023 Q2	$84.6K	Sell	948 -17	-2%	-$1.48K	﹤0.01%	3308
2023 Q1	$103K	Buy	965 +603	+167%	+$69K	﹤0.01%	3320
2022 Q4	$44.2K	Sell	362 -438	-55%	-$50.9K	﹤0.01%	3445
2022 Q3	$82.6K	Buy	800 +75	+10%	+$7.11K	﹤0.01%	3842
2022 Q2	$67.4K	Buy	+725	New	+$68.3K	﹤0.01%	3481
2022 Q1	–	Sell	-11,191	Closed	-$1.51M	–	4162
2021 Q4	$1.51M	Buy	+11,191	New	+$1.66M	﹤0.01%	2280
2020 Q2	–	Sell	-12,100	Closed	-$1.36M	–	4313
2020 Q1	$1.36M	Buy	+12,100	New	+$1.57M	﹤0.01%	1709

Other funds holding ASND

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets's ASND Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Ascendis Pharma A/S (ASND) stake by 44% in Q2 2026, selling an estimated $31.7M and leaving 173,449 shares worth $46.3M. The position accounts for 0.02% of the portfolio, ranked #804.

BNP Paribas Financial Markets first reported a position in ASND in Q1 2020 and has held it in 19 quarters since. The position peaked at $70.7M in Q1 2026. 209 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

BNP Paribas Financial Markets held 173,449 shares of Ascendis Pharma A/S worth $46.3M as of Q2 2026.
BNP Paribas Financial Markets sold 135,724 Ascendis Pharma A/S shares in Q2 2026, an estimated $31.7M.
Ascendis Pharma A/S made up 0.02% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #804 holding.
BNP Paribas Financial Markets first reported a position in Ascendis Pharma A/S in Q1 2020 and has held it in 19 quarters since.
BNP Paribas Financial Markets's Ascendis Pharma A/S position peaked at $70.7M in Q1 2026.
209 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.